– Clinical evaluation of patients with kidney tumours should provide several parameters with possible prognostic value, such as age, sex, incidental discovery, duration of symptoms, weight loss, fever, disease-free interval, performance status, elevated ESR, hypercalcemia, elevated gamma-enolase, local tumour extension, invasion of renal vein and inferior vena cava, lymphatic metastases, distant metastases, tumour dimension, multicentricity, bilaterality and growth velocity. Some of these factors correlate to prognosis in univariate statistical analysis; in multivariate analysis, however, tumour stage is the best prognostic factor, while the other parameters show less or no prognostic value. Besides tumour stage, parameters with an independent value are performance status, weight loss, elevated ESR. Using these prognostic factors, patients can be divided into groups with different prognosis and treatment.
DollR., PetoR.: Epidemiology of cancer. In: WeatherhallD.J., LedinghamG.G., WarrelD.A. eds., Oxford Textbook of Mediane, Oxford, 4: 95, 4: 123, 1987.
2.
StenzleA., deKernionJ.B.: Pathology, biology, and clinical staging of renal cell carcinoma. Sem. Oncol., 16: 3–11, 1989.
3.
SkinnerD.G., ColvinR.B., VermillionC.D., PfisterR.C., LeadbetterW.F.: Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 28: 1165, 1971.
4.
DelahuntB., BethwaiteP., NaceyJ.: Renal cell carcinoma in New Zealand: a national survival study. Urology, 43 (3): 300–309, 1994.
5.
LieberM.M., TomeraF.M., TaylorW.F., FarrowG.M.: Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J. Urol., 125: 164–168, 1981.
6.
NobleJ.G., ParikhA.M., ChappieC.R., WorthP.H., MilroyE.J.: Renal adenocarcinoma in young adults. Urol. Int., 53 (1): 40–43, 1994.
LackE.E., CassadyJ.R., SallanS.E.: Renal cell carcinoma in childhood and adolescence. A clinical and pathological study of 17 cases. J. Urol., 133: 822: 1985.
9.
GelbA.B., ShibuyaR.B., WeissL.M., MedeirosL.J.: Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am. J. Surg. Pathol., 17 (3): 275–286, 1993.
10.
SteinbachF., StokleM., KiewelR., StorkelR., SteinR., HohenfellnerR.: Prognostic parameters of renal cell carcinoma. Clinicopathologic and DNA image cytometric analysis in 133 pT3a cases. Eur. Urol., 24: 279–285, 1993.
11.
van der PoelH.G., MuldersP.F.A., OosterhofG.O.N., SchaafsmaH.E., HendriksJ.C.M., SchalkenJ.A., DebruyneF.M.J.: Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumour heterogeneity. Cancer, 72: 2667–2674, 1993.
12.
ArtachoPerula E., RoldanVillalobos R., MartinezCuevas J.F.: Value of volume weighted mean nuclear volume in grading and prognosis of renal cell carcinoma. J. Clin. Pathol., 47 (4): 324–328, 1994.
13.
McNicholsD.W., SeguraJ.W., De WeedJ.H.: Renal cell carcinoma: long-term survival and late recurrence. J. Urol., 126: 17–23, 1981.
14.
EskelinenM., LipponenP., Aitoo-OjaL., HallO., SysjanenK.: The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. Int. J. Cancer, 55: 547–554, 1993.
15.
SelliC., HinshawW.M., WoodardB.H., PaulsonD.F.: Stratification of risk factors in renal cell carcinoma. Cancer, 52: 899–903, 1983.
16.
NurmiM.J.: Prognostic factors in renal carcinoma. An evaluation of operative findings. Br. J. Urol., 56: 270–275, 1984.
GreenL.K., AyalaA.G., RoJy. : Role of nuclear grading in stage I renal cell carcinoma. Urology, 34: 310, 1989.
20.
CohenA.J., LiF.P., BergS.: Hereditary renal cell carcinoma associated with a chromosomal translocation. N. Engl. J. Med., 301: 592–5, 1979.
21.
PathakS., StromgL.C., FerreiR.E., TrindadeA.: Familial renal cell carcinoma with a 3:11 chromosome translocation limited to tumour cells. Science, 217: 939–41, 1982.
22.
Punga MaoleM.L., HubertJ., GrignonY., FloquetJ., ManginP.: Les tumeurs tubulo-papillaires du rein. Particularités cliniques, histologiques et cytogenetiques. A propos de 15 nouvelles observations. Prog. Urol., 4 (6): 977–986, 1994.
23.
TruongL.D., KrishnanB., CaoJ.T., BarriosR., SukiW.N.: Renal neoplasm in acquired cystic kidney disease. Am. J. Kidney Dis., 26 (1): 1–12, 1995.
24.
DunnilM.S., MillardP.R., OliverD.: Acquired cystic disease of the kidney: a hazard of long-term intermittent maintenance haemodialisys. J. Clin. Pathol., 30: 868–77, 1977.
25.
GoreyT., SpeesE.K., SapierD.: Renal malignancies are increased in transplantation candidates [Abstract]. J. Urol., 131: 230A, 1984.
26.
ChristensenP.J., CraigJ.P., BibroM.C., O'ConnelK.J.: Cysts containing renal cell carcinoma in von Hippel-Lindau disease. J. Urol., 128: 798–800, 1982.
27.
SolomonD., SchwartzA.: Renal pathology in von Hippel-Lindau disease. Hum. Pathol., 19: 1072–9, 1988.
28.
NovickA.C., StreemS.B.: Long-term follow-up after nephron sparing surgery for renal cell carcinoma in von Hippel-Lindau disease. J. Urol., 147: 1488–1490, 1992.
29.
HortonW.A., WongV., EldrichR.: von Hippel-Lindau disease: clinical and pathological manifestations in nine families with 50 affected members. Arch. Intern. Med., 136: 769, 1976.
30.
RichardsR.D., MebustW.K., SchimkeR.N.: A prospective study of von Hippel-Lindau disease. J. Urol., 110: 27, 1973.
31.
ChristofersonL.A., GustafsonM.B., PetersenA.G.: von Hippel-Lindau disease. JAMA, 178: 280, 1961.
32.
OzenH., ColowickA., FreihaF.S.: Incidentally discovered solid renal masses: what are they?Br. J. Urol., 72 (3): 274–276, 1993.
33.
MollV., BechtE., ZieglerM.: Kidney preserving surgery in renal cell tumours: indications, techniques and results in 152 patients. J. Urol., 150: 319–323, 1993.
34.
ReussJ.: Der Nierentumour als sonographischer Zufallsbefund (A kidney tumour as an incidental ultrasound finding). Ultraschall. Med., 15 (4): 163–167, 1994.
35.
OjeaCalvo A., RodriguezIglesias B., AlonsoRodrigo A., VerezVivero M., BenaventeDelgado J., BarrosRodriguez J.M., NogueiraMarch J.L.: Analisis de 88 adenocarcinomas de rinon: evoluacion en el diagnostico y en el pronostico. Arch. Esp. Urol., 18 (7): 703–705, 1994.
36.
SaikaT., YamamotoY., TakedaK., AsahiT.: Influential clinical and pathological factors on prognosis of renal cell carcinoma. Hinyokika Kiyo, 40 (3): 189–193, 1994.
ThompsonI.M., PeekM.: Improvement in survival of patients with renal cell carcinoma: the role of the serendipitously detected tumours. J. Urol., 140: 487–490, 1988.
LoizagaIriarte A., ArceoSantiago R., UllateJaime V., UndaUrzaiz M., FloresCorral N.: Adenocarcinoma renal corno hallazgo incidental. Diagnostico y evolucion tumoral. Arch. Esp. Urol., 48 (3): 261–265, 1995.
41.
JakobsenE.B., EickhoffJ.H., AndersenJ.P., OttesenM.: Prognosis after nephrectomy for renal cell carcinoma. Scand. J. Urol. Nephrol., 28 (3): 229–236, 1994.
42.
SeneA.P., HuntL., McMahonR.F.T., CarrolR.N.P.: Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. Br. J. Urol., 70: 125–134, 1992.
43.
OnishiT., MachidaT., MasudaF., IizukaN., ShirakawaH., HatanoT., MakinoH.: Evaluation of prognostic factors in patients with stage 1 renal cell carcinoma. Nippon Hinyokika Gakkai Zasshi, 84 (4): 757–762, 1993.
44.
Rivas delFresno M., FernandezGomez J.M., San MartinBlanco A., SahagunArguello J.L., MartinBenito J.L., AlonsoSainz F.: Nuestra experiencia en adenocarcinomas renales (II): clinica, diagnostico y factores pronosticos antes del tratamiento quirurgico. Arch. Esp. Urol., 48 (1): 67–71, 1995.
45.
FossaS.D., KramarA., DrozJ.P.: Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alfa. Eur. J. Cancer, 30A (9): 1310–4, 1994.
46.
WagstaffJ., BaarsJ.W., WolbinkGj., HoekmanK., Eerenberg-BelmerA.J.M., HackC.E.: Renal cell carcinoma and interleukin-2: a review. Eur. J. Cancer, 31A (3): 401–408, 1995.
47.
ManiS., ToddM.B., KatzK., PooW.J.: Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J. Urol., 154 (1): 35–40, 1995.
48.
LandonioG., BaiocchiC., CattaneoD., FerrariM., GottardiO., MajnoM., GhislandiE.: Retrospective analysis of 156 cases of metastatic renal cell carcinoma: evaluation of prognostic factors and response to different treatments. Tumori, 80 (6): 468–472, 1994.
49.
CanobbioL., RubagottiA., MigliettaL., CannataD., CurottoA., AmorosoD., BoccardoF.: Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alpha. J. Cancer Res. Clin. Oncol., 121 (12): 753–756, 1995.
50.
SchmitzDrager B.J., JankeviciusF., OttoT.: Prognostic factors for predicting the success of immunotherapy in metastatic renal cell carcinoma. Urologe, 34 (3): 195–199, 1995.
51.
LissoniP., BamiS., ArdizzoiaA., CrispinoS., PaolorossiF., AndresM., ScardinoE., TanciniG.: Prognostic factors of the clinical response to subcutaneous immunotherapy with interleukin-2 alone in patients with metastatic renal cell caranoma. Oncology, 51: 59–62, 1994.
52.
OnishiT., OnishiY., MasudaF., IizukaN., SuzukiY., ShirakawaH., HatanoT., TornitaM.: Prognostic factors in patients with stage 4B renal cell carcinoma following nephrectomy. Nippon Hinyokika Gakkai Zasshi, 85 (11): 1664–1672, 1994.
CzaplickiM., BorkowskyA., WesolowskyS.: Late results of surgical treatment of renal clear-cell carcinoma. Int. Urol. Nephrol., 18: 37, 1986.
63.
GiulianiL., GibertiC., MartoranaG., RovidaS.: Radical extensive surgery for renal cell carcinoma: long-term results and prognostic factors. J. Urol., 143: 468–474, 1990.
64.
DinneyC.P.N., AwadS.A., GajewskyJ.B.: Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology, 39: 122: 1992.
65.
LaniganD., McLeanP.A., MurphyD.M., DonovanM.G., CurranB., LeaderM.: Ploidy and prognosis in renal cell carcinoma. Br. J. Urol., 71: 21–24, 1993.
66.
YuD.S., LeeW.H., ChangS.Y., MaC.P.: Flow cytometric DNA and cytomorphometric analysis in renal cell carcinoma: its correlation with histopathology and prognosis. J. Surg. Res., 55 (5): 480–5, 1993.
67.
ThrasherJ.B., PaulsonD.F.: Prognostic factors in renal cancer. Urol. Clin. North Am., 20 (2): 247–262, 1993.
68.
BotF.J., GodschalkJ.C., KrishnadathK.K., van der KwastT.H., BosmanF.T.: Progrostic factors in renal cell carcinoma: immunohistochemical detection on p53 protein versus clinico-pathological parameters. Int. J. Cancer, 57 (5): 634–637, 1994.
69.
LarssonP.: Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis. Scand. J. Urol. Nephrol., 165 (suppl.): 1–48, 1994.
70.
SiminovitchJ.M., MontieJ.E., StraffonR.A.: Prognostic indicators in renal adenocarcinoma. J. Urol., 130: 20–23, 1983.
71.
BoxerR.J., WaismanJ., LieberM.M.: Renal carcinoma: computer analysis of 96 patients treated with nephrectomy. J. Urol., 122: 598–601, 1979.
72.
SwierzewskiD.J., SwierzewskiM.J., LibertinoJ.A.: Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval and atrial extension. Am. J. Surg., 168: 205–209, 1994.
73.
TongaonkarH.B., DandekarN.P., DalaiA.V., KulkarniJ.N., KamatM.R.: Renal cell caranoma extending to the renal vein and inferior vena cava: results of surgical treatment and prognostic factors. J. Surg. Oncol., 59 (2): 94–100, 1995.
CherrieR.J., GoldmanD.G., LinderA., DeKernionJ.B.: Prognostic implications of vena cava extension of renal cell carcinoma. J. Urol., 128: 910–912, 1982.
76.
HatcherP.A., AndersonE.E., PaulsonD.F., RobertsonJ.E.: Surgical management and prognosis of renal cell carcinoma invading the vena cava. J. Urol., 145: 20–24, 1991.
77.
LibertinoJ.A., ZinmanL., WatkinsE.: Long-term results of resection of renal cell cancer with extension into inferior vena cava. J. Urol., 137: 21–24, 1987.
78.
O'DonohueM.K., FlanaganF., FitzpatrickJ.M., : Surgical approach to inferior vena caval extension of renal carcinoma. Br. J. Urol., 60: 492, 1987.
79.
SosaR.E., MueckeE.C., VaughanE.D.Jr.: Renal cell carcinoma extending into the inferior vena cava: the prognostic significance of the level of vena caval involvement. J. Urol., 132: 1097, 1984.
80.
StaehlerG., DrehmerI., PomerS.: Tumour involvement of the vena cava in renal cell carcinoma. Surgical technique, results and prognosis. Urologe, 33 (2): 116–121, 1994.
81.
GohjiK., YamashitaC., UenoK., ShimogakiH., KamidonoS.: Preoperative computerized tomography detection of extensive invasion of the inferior vena cava by renal cell carcinoma: possible indication for resection with partial cardiopulmonary bypass and patch grafting. J. Urol., 152: 1993–1997, 1994.
82.
AmendolaM.A., BreeR.L., PollackH.M., : Small renal cell carcinomas: resolving a diagnostic dilemma. Radiology, 166: 637–641, 1988.
83.
MukamelE., KonichezkyM., EngelsteinD., ServadioC.: Incidental small renal tumours accompanying clinically overt renal cell carcinoma. J. Urol., 140: 22–24, 1988.
84.
MorganW.R., ZinckeH.: Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended follow-up. J. Urol., 144: 852–858, 1990.
85.
ChengW.S., FarrowG.M., ZinckeH.: The incidence of multicentricity in renal cell carcinoma. J. Urol., 146: 1221–1223, 1991.
86.
VietsD.H., VaughanE.D.Jr., HowardsS.S.: Experience gained from the management of 9 cases of bilateral renal cell carcinoma. J. Urol., 118: 937–940, 1977.
CurryN.S., SchabelS.I., BetsillW.L.: Small renal neoplasms: diagnostic imaging, pathologic features, and clinical course. Radiology, 158: 113–117, 1986.
89.
LevineE., HuntrakoonM., WetzelL.H.: Small renal neoplasms: clinical, pathologic and imaging features. AJR, 153: 69–73, 1989.
90.
ZagoriaR.J., WolfmanN.T., KarstaedtN., HinnG.C., DyerR.B., ChenY.M.: CT features of renal cell carcinoma with emphasis on relation to tumour size. Invest. Radiol., 25: 261–266, 1990.
91.
OsanaiH., TokunakaS., YachikuS., HorilO.: Localisation of small renal rumour by dynamic computerized tomography. Urology, 38: 460–65, 1991.
92.
YamashitaY., TakahashiM., WatanabeO., : Small renal cell carcinoma: pathologic and radiologic correlation. Radiology, 184: 493–498, 1992.
93.
PratiG.F., SagginP., BoschieroL., MartiniP.T., MontemezziS., MuoioA.: Small renal-cell carcinoma: clinical and imaging features. Urol. Int., 51: 19–22, 1993.
94.
EkelundL., JonssonK.: Growth rate of renal carcinoma as demonstrated by repeat angiography. Acta Radiol. Diagn., 17: 786–789, 1976.
95.
BosniakM.A.: Problems in the radiologic diagnosis of renal parenchymal tumours. Urol. Clin. North Am., 20 (2): 217–230, 1993.
